Menu Search
Equities

ProstaLund AB

7PL:FRA

ProstaLund AB

Actions
  • Price (EUR)0.0052
  • Today's Change0.001 / 23.81%
  • Shares traded1.00k
  • 1 Year change-95.53%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 07:02 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year ProstaLund AB's net income fell 53.27% from a loss of 11.10m to a larger loss of 17.01m despite revenues that grew 27.54% from 17.41m to 22.21m. An increase in the selling, general and administrative costs as a percentage of sales from 112.99% to 121.75% was a component in the falling net income despite rising revenues.
Gross margin72.73%
Net profit margin-123.16%
Operating margin-122.37%
Return on assets-32.35%
Return on equity-40.22%
Return on investment-39.54%
More ▼

Cash flow in SEKView more

In 2023, ProstaLund AB increased its cash reserves by 25.05%, or 3.08m. Cash Flow from Financing totalled 30.22m or 136.09% of revenues. In addition the company used 23.80m for operations while cash used for investing totalled 3.35m.
Cash flow per share--
Price/Cash flow per share--
Book value per share0.5656
Tangible book value per share0.1648
More ▼

Balance sheet in SEKView more

ProstaLund AB appears to have a strong balance sheet and has grown its cash reserves consistently over the last four years to total 15.02m. In fact, 0.31% of the value of ProstaLund AB shares can be attributed to this cash.
Current ratio2.06
Quick ratio0.7618
Total debt/total equity0.1192
Total debt/total capital0.1065
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.